Normally, CD4+ Th cells do not directly demolish malignant tumor cells, but they support the development of tumor immunity by recognizing tumor antigen peptides presented by MHC class II molecules and amplifying the activation and clonal expansion of CTL [60]. The gene discussed is CD4; the disease is neoplasm.